Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users

NCT01579734 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1884

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Tamoxifen
DRUG: Placebo

Sponsor

European Institute of Oncology